Evidence map›Paper›PMID 41888414›Full record

ArticleNaunyn-Schmiedeberg's archives of pharmacology2026

Cerebroprotective potential of ceftriaxone against cadmium chloride-induced cerebral inflammatory changes and oxidative insult.

Mansi Chaudhary, Prabhat Singh, Surbhi Gupta, Vishal Kumar Biswkarma, Priyadarshini Soni, Lubhan Singh

Abstract read
PubMed Publisher
In one paragraph

Article in Naunyn-Schmiedeberg's archives of pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mansi ChaudharyFaculty of Pharmacy, Swami Vivekanand Subharti University, Meerut, Uttar Pradesh, India.
Prabhat SinghFaculty of Pharmacy, Swami Vivekanand Subharti University, Meerut, Uttar Pradesh, India. prabhatsingh509@gmail.com.ORCID http://orcid.org/0000-0002-1767-1308
Surbhi GuptaDepartment of Pharmacology, School of Pharmacy, Bharat Institute of Technology, Partapur Bypass, Meerut, Uttar Pradesh, India. surbhi02gupta@gmail.com.ORCID http://orcid.org/0000-0002-6178-5759
Vishal Kumar BiswkarmaFaculty of Pharmacy, Swami Vivekanand Subharti University, Meerut, Uttar Pradesh, India.
Priyadarshini SoniFaculty of Pharmacy, Swami Vivekanand Subharti University, Meerut, Uttar Pradesh, India.
Lubhan SinghFaculty of Pharmacy, Swami Vivekanand Subharti University, Meerut, Uttar Pradesh, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cadmium (Cd) is a potent neurotoxic heavy metal associated with cerebral oxidative disturbances. The beta-lactam antibiotic ceftriaxone has been known to modulate the expression of GLT-1, the primary glutamate transporter. This research has been framed to evaluate the potential neurodefensive activity of ceftriaxone against cadmium chloride (CdCl

Indexed as

BrainCadmium ChlorideCeftriaxoneNeuroinflammatory DiseasesNeuroprotective AgentsOxidative StressAnimalsBehavior, AnimalBrain-Derived Neurotrophic FactorMaleMiceBrain-Derived Neurotrophic FactorCadmium ChlorideCeftriaxoneNeuroprotective AgentsAntioxidantCadmium chlorideCadmium neurotoxicityGlutamate transportersNeuroinflammationNeurotrophic protein

Identifiers

PMID41888414

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.